Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DEAM is a medical technology company based in the Netherlands that specializes in the design and manufacture of steerable instruments for minimally invasive surgery. The company's core innovation is the LaproFlex, a disposable steerable laparoscopic grasper that provides surgeons with 360-degree tip rotation and enhanced dexterity. By utilizing a unique mechanical steering mechanism, DEAM's products allow for complex maneuvers in tight anatomical spaces that are difficult to reach with conventional rigid tools. The company originated as a spin-off from the Delft University of Technology and the Academic Medical Center in Amsterdam, leveraging academic research to solve clinical challenges in laparoscopy. DEAM aims to improve surgical precision and patient outcomes while maintaining a cost-effective, disposable business model. Their technology is currently focused on abdominal surgery, gynecology, and urology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DEAM.